Invention Grant
- Patent Title: Methods of treating FGF21-associated disorders
-
Application No.: US15749775Application Date: 2016-08-02
-
Publication No.: US11236159B2Publication Date: 2022-02-01
- Inventor: Brian Boettcher , Shari Lynn Caplan , Regis Cebe , Guochun Li , John A. Taraszka , Fangmin Xu , David Langdon Yowe
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Clark & Elbing LLP
- International Application: PCT/IB2016/054660 WO 20160802
- International Announcement: WO2017/021893 WO 20170209
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P3/00 ; A61K39/00
Abstract:
The present invention relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human β-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
Public/Granted literature
- US20200087392A1 METHODS OF TREATING FGF21-ASSOCIATED DISORDERS Public/Granted day:2020-03-19
Information query
